[1]
GANGULA, C.V. et al. 2025. DEVELOPMENT AND OPTIMIZATION OF SOLID LIPID NANOPARTICLES OF ERLOTINIB USING DESIGN OF EXPERIMENTS: IN VITRO DRUGRELEASE AND IN VIVO PHARMACOKINETIC STUDIES. International Journal of Applied Pharmaceutics. 17, 5 (Sep. 2025), 320–331. DOI:https://doi.org/10.22159/ijap.2025v17i5.53909.